High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.1M
$7,139,970
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$94,205
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $94,205 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $424,120 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $114,851 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $423,760 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$99,378
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $99,378 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2026-02-23
$48,352
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-02-23 | $48,352 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $227,593 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $52,097 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $227,618 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2026-02-02
$50,516
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-02-02 | $50,516 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-16 | $27,299 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-16 | $27,701 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Cohen Joshua B
• CEO
Discretionary Sell
2026-01-15
$1,850,795Large
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-15 | $1,850,795Large | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Klee Justin B.
• CEO
Discretionary Sell
2026-01-15
$1,849,869Large
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-15 | $1,849,869Large | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-06 | $85,596 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-06 | $36,954 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-06 | $85,589 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2025-12-01
$94,418
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-01 | $94,418 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2025-09-30
$175,518
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-09-30 | $175,518 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2025-09-30 | $429,469x2 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2025-09-30 | $154,650 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2025-09-30 | $430,952x2 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2025-09-30
$128,669
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-09-30 | $128,669 | S | Form 4 |